Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Ruffell

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinomaAnusha-Preethi Ganesan, Magnus Johansson, Brian Ruffell, et al.
Cancer Cell|January 10, 2018
TIM-3 Regulates CD103<sup>+</sup> Dendritic Cell Function and Response to Chemotherapy in Breast CancerÁlvaro de Mingo Pulido, Alycia Gardner, Shandi Hiebler, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
Journal for Immunotherapy of Cancer|January 6, 2022
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localizationAlycia Gardner, Álvaro de Mingo Pulido, Kay Hänggi, et al.
Journal for Immunotherapy of Cancer|August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma modelsManali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Genes & Development|September 26, 2013
Cathepsin C is a tissue-specific regulator of squamous carcinogenesisBrian Ruffell, Nesrine I Affara, Lucia Cottone, et al.
Cancer Cell|December 3, 2014
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cellsBrian Ruffell, Debbie Chang-Strachan, Vivien Chan, et al.
Nature Immunology|June 27, 2022
LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognitionQianqian Ming, Daiana P Celias, Chao Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticlesHeike E Daldrup-Link, Daniel Golovko, Brian Ruffell, et al.
Oncotarget|October 21, 2016
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical modelsAdam R Wolfe, Nicholaus J Trenton, Bisrat G Debeb, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinomaAnusha-Preethi Ganesan, Magnus Johansson, Brian Ruffell, et al.
Cancer Cell|January 10, 2018
TIM-3 Regulates CD103<sup>+</sup> Dendritic Cell Function and Response to Chemotherapy in Breast CancerÁlvaro de Mingo Pulido, Alycia Gardner, Shandi Hiebler, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
Journal for Immunotherapy of Cancer|January 6, 2022
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localizationAlycia Gardner, Álvaro de Mingo Pulido, Kay Hänggi, et al.
Journal for Immunotherapy of Cancer|August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma modelsManali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Genes & Development|September 26, 2013
Cathepsin C is a tissue-specific regulator of squamous carcinogenesisBrian Ruffell, Nesrine I Affara, Lucia Cottone, et al.
Cancer Cell|December 3, 2014
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cellsBrian Ruffell, Debbie Chang-Strachan, Vivien Chan, et al.
Nature Immunology|June 27, 2022
LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognitionQianqian Ming, Daiana P Celias, Chao Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticlesHeike E Daldrup-Link, Daniel Golovko, Brian Ruffell, et al.
Oncotarget|October 21, 2016
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical modelsAdam R Wolfe, Nicholaus J Trenton, Bisrat G Debeb, et al.
Pageof 7